Patient’s Laboratory Investigations
Parameters | Patient’s Values | Reference Range |
---|---|---|
Thyroid-stimulating hormone, µIU/mL | 1.42 | 0.7–5.97 |
Free thyroxine, ng/dL | 1.13 | 0.7–1.48 |
IGF-1, ng/mL | 181 | 74–388 |
GAD65, IU/mL | 2.27 | Cutoff: 5.0 |
IA2, IU/mL | 6.18 | Cutoff: 8.0 |
Lactate, mmol/L | 4.5 | 0.5–2.2 |
Cortisol (8:00 a.m.), µg/dL | 14.5 | 3.7–19.4 |
Luteinizing hormone, µIU/mL | 2.92 | 1.14–8.75 |
Follicle-stimulating hormone, µIU/mL | 0.81 | 0.95–11.95 |
Testosterone, ng/mL | 4.91 | 1.56–8.77 |
Adrenocortotropic hormone, pg/mL | 98 | 7.2–63.3 |
Creatine phosphokinase, U/L | 153 | 0–171 |
A1C, % | 8.4 | Normal <6.5% |
Stool fat | Negative | |
Computed tomography scan of brain | Normal | |
Multidetector computed tomography of the abdomen | No abnormality detected | |
Two-dimensional echocardiogram | Myxomatous mitral valve, prolapsed anterior mitral leaflet with trivial mitrial regurgitation | |
Endoscopy with duodenum biopsy | Normal |